Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease

Author:

Lee Min Jae1,Bhattarai Deepak1,Jang Hyeryung2,Baek Ahreum3,Yeo In Jun4,Lee Seongsoo2,Miller Zachary1,Lee Sukyeong5,Hong Jin Tae4,Kim Dong-Eun3ORCID,Lee Wooin2ORCID,Kim Kyung Bo1ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Kentucky, 789 South Limestone, Lexington, Kentucky 40536-0596, United States

2. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea

3. Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea

4. College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea

5. Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, United States

Funder

National Cancer Institute

National Research Foundation of Korea

Seoul National University

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3